A detailed history of Neuberger Berman Group LLC transactions in Pfizer Inc stock. As of the latest transaction made, Neuberger Berman Group LLC holds 13,797,650 shares of PFE stock, worth $379 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
13,797,650
Previous 15,252,383 9.54%
Holding current value
$379 Million
Previous $423 Million 8.79%
% of portfolio
0.33%
Previous 0.36%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$25.26 - $29.6 $36.7 Million - $43.1 Million
-1,454,733 Reduced 9.54%
13,797,650 $386 Million
Q1 2024

May 13, 2024

BUY
$25.89 - $29.73 $395 Million - $453 Million
15,252,383 New
15,252,383 $423 Million
Q4 2023

Feb 09, 2024

BUY
$26.13 - $33.94 $17.4 Million - $22.6 Million
666,784 Added 3.91%
17,702,349 $510 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $106 Million - $123 Million
3,292,002 Added 23.95%
17,035,565 $565 Million
Q2 2023

Aug 11, 2023

SELL
$36.12 - $41.79 $1.98 Million - $2.3 Million
-54,920 Reduced 0.4%
13,743,563 $504 Million
Q1 2023

May 12, 2023

BUY
$39.39 - $51.28 $57.4 Million - $74.7 Million
1,456,337 Added 11.8%
13,798,483 $563 Million
Q4 2022

Feb 13, 2023

SELL
$41.75 - $54.5 $38.9 Million - $50.8 Million
-931,535 Reduced 7.02%
12,342,146 $633 Million
Q3 2022

Nov 15, 2022

BUY
$43.76 - $53.42 $46.5 Million - $56.7 Million
1,061,894 Added 8.7%
13,273,681 $581 Million
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $103 Million - $122 Million
2,208,244 Added 22.07%
12,211,787 $640 Million
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $22.9 Million - $28.3 Million
499,802 Added 5.26%
10,003,543 $513 Million
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $4.95 Million - $7.34 Million
119,903 Added 1.28%
9,503,741 $556 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $32.5 Million - $41.8 Million
828,318 Added 9.68%
9,383,838 $401 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $119 Million - $135 Million
3,317,439 Added 63.33%
8,555,520 $334 Million
Q1 2021

May 13, 2021

SELL
$33.49 - $37.77 $34.8 Million - $39.3 Million
-1,039,370 Reduced 16.56%
5,238,081 $189 Million
Q4 2020

Feb 10, 2021

SELL
$33.47 - $42.56 $16.8 Million - $21.4 Million
-503,307 Reduced 7.42%
6,277,451 $231 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $16.8 Million - $19.7 Million
-528,821 Reduced 7.23%
6,780,758 $236 Million
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $21 Million - $25.4 Million
-695,922 Reduced 8.69%
7,309,579 $239 Million
Q1 2020

May 14, 2020

SELL
$27.03 - $38.62 $19.3 Million - $27.6 Million
-715,748 Reduced 8.21%
8,005,501 $248 Million
Q4 2019

Feb 12, 2020

SELL
$32.92 - $37.36 $58.6 Million - $66.5 Million
-1,779,890 Reduced 16.95%
8,721,249 $342 Million
Q3 2019

Nov 13, 2019

SELL
$32.49 - $42.13 $37 Million - $48 Million
-1,138,695 Reduced 9.78%
10,501,139 $377 Million
Q2 2019

Aug 13, 2019

SELL
$36.98 - $41.52 $28.4 Million - $31.9 Million
-768,736 Reduced 6.2%
11,639,834 $504 Million
Q1 2019

May 13, 2019

SELL
$37.5 - $41.2 $34.9 Million - $38.3 Million
-930,398 Reduced 6.98%
12,408,570 $527 Million
Q4 2018

Feb 12, 2019

SELL
$38.47 - $43.86 $39.3 Million - $44.8 Million
-1,022,438 Reduced 7.12%
13,338,968 $582 Million
Q3 2018

Nov 13, 2018

SELL
$34.47 - $41.81 $28.2 Million - $34.2 Million
-818,602 Reduced 5.39%
14,361,406 $633 Million
Q2 2018

Aug 13, 2018

SELL
$32.98 - $35.16 $28.9 Million - $30.8 Million
-876,102 Reduced 5.46%
15,180,008 $551 Million
Q1 2018

May 08, 2018

BUY
$31.91 - $37.02 $77.6 Million - $90.1 Million
2,432,694 Added 17.86%
16,056,110 $570 Million
Q4 2017

Feb 14, 2018

SELL
$33.26 - $35.29 $25 Million - $26.5 Million
-751,529 Reduced 5.23%
13,623,416 $494 Million
Q3 2017

Nov 15, 2017

BUY
$31.0 - $34.15 $446 Million - $491 Million
14,374,945
14,374,945 $513 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.